Scientists identify progenitor cells that could revolutionize osteoarthritis treatment

Researchers report that osteoarthritis is caused by the loss of Gremlin 1 (Grem1)-lineage chondrogenic progenitor cells.

Q&A: Jade CEO talks about reverse merger and IgAN drugs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 1, 2024

Signal: Wegovy cuts cardiovascular risk by 20% for heart disease patients – Pharmaceutical Technology

Wegovy cuts cardiovascular risk in those with existing conditions by 20%. Photo: Michael Siluk/UCG/Universal Images Group via Getty Images. Novo Nordisk’s blockbuster weight-loss drug Wegovy

November 13, 2023

The case of the armadillo: Is it spreading leprosy in Florida?

In an open-air barn at the edge of the University of Florida, veterinarian Juan Campos Krauer examines a dead armadillo’s footpads and ears for signs

May 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.